Related Experiment Video
Updated: Jan 14, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
The clinical profile and therapeutic outcome of patients diagnosed with "atypical" optic neuritis
Gülden Akdal1,2, Hülya Ertaşoğlu Toydemir3, Meltem Söylev Bajin4
1Faculty of Medicine, Department of Neurology, Dokuz Eylül University, Izmir, Turkey. gulden.akdal@deu.edu.tr.
Purpose:
Our aim was to evaluate the clinical characteristics and prognosis of patients diagnosed with atypical optic neuritis (AON).
Methods:
We performed a retrospective study in patients with AON collected between 1991 and 2024. Clinical features, laboratory findings, and treatment modalities of patients with AON were investigated and the relationship between therapeutic approaches and the visual prognosis of these patients were evaluated.
Results:
Eighty-eight patients with AON were evaluated and 51 patients were included in the study. Patients were divided in two groups (Group 1: full recovery, Group 2: partial and no recovery). Anti-MOG antibodies were positive in 8 patients. Seven patients out of 8 had full recovery whereas 1 patient had partial recovery. Among 7 patients with AQP4-Ab positivity, 4 patients had no recovery, 1 patient had partial recovery and 2 patients had full recovery. MOG-Ab positivity and intravenous methylprednisolone (IVMP) treatment in patients with full recovery were found to be significantly higher than in patients with partial recovery and no recovery (p = 0.011 and p = 0.010 respectively). Patients who were treated with plasma exchange (PE), intravenous immunoglobulin (IVIg) and immunsupressive agents had longer recovery time according to Kaplan -Meier survival curves (p = 0.023, p = 0.039 and p = 0.032).
Conclusion:
MOG-Ab positivity and IVMP treatment are related with better visual outcome. Early diagnosis and treatment of AON are extremely important to rescue vision. Treatment in patients with AON should be started as soon as possible, even if the serological status is not known at the setting of ON.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Psychosis: Goals of Pharmacotherapy

